Secondaries announced 11.01.2016
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: RedHill Biopharma Ltd. Symbol: RDHL Price: Last trade $11.80 Description: No re-offer range available Trade Date: 11/2 Shares: TBD Underwriter(s)Roth Capital[…]
